Actiq lozenges and Instanyl nasal spray are both licensed for the treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid…
A UKMi Product Safety assessment on Zalviso® (sufentanil citrate) sublingual tablets which describes the in-use medication safety considerations resultant from the product’s presentation or other…
A UKMi Product Safety assessment on Onexila® XL (oxycodone once daily prolonged release tablets); in-use medication safety considerations resultant from the product presentation or other…